Komori
Uex (9888) · RiskGoodwill balance declines; no indication of impairment

Goodwill impairment risk

First written in FY2021. 1 of 10 entries say "Mitigated", first in FY2022. Latest entry: FY2026.

10entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021MitigatedFY2022OtherFY2023 – FY20262021: 120212022: 120222023: 220232024: 320242025: 220252026: 12026
Same theme, other companies
Impairment of Goodwill and Trademark Rights Associated with AcquisitionsA theme 206 companies write about · 208 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2023: 35 of 98 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 208 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Goodwill balance declines; no indication of impairmentAnnual report

    「The Company determined that there were no indications of goodwill impairment during the current consolidated fiscal year. However, if the estimates and assumptions need to be revised due to changes in uncertain future economic conditions or other factors, an impairment loss (extraordinary loss) could arise in the consolidated financial statements for the next consolidated fiscal year.」

    The goodwill balance decreased through amortization from ¥202.004 million at the end of the previous fiscal year to ¥50.501 million, and the Company determined that there were no indications of impairment during the current fiscal year. However, the risk of impairment due to future economic conditions and other factors continues.
  2. FY2026-H1Goodwill balance decreasedAnnual report

    「Goodwill 202,004 126,252」

    The goodwill balance decreased from ¥202.004 million at the end of the previous consolidated fiscal year to ¥126.252 million at the end of the current interim consolidated accounting period.
  3. FY2025Goodwill balance declines; no indication of impairmentAnnual report

    「The Company determined that there were no indications of goodwill impairment during the current consolidated fiscal year. However, if the estimates and assumptions need to be revised due to changes in uncertain future economic conditions or other factors, an impairment loss (extraordinary loss) could arise in the consolidated financial statements for the next consolidated fiscal year.」

    The goodwill balance decreased through amortization from ¥353.506 million at the end of the previous fiscal year to ¥202.004 million, and the Company determined that there were no indications of impairment during the current fiscal year. However, the risk of impairment due to future economic conditions and other factors continues.
  4. FY2025-H1Decrease in goodwill balanceAnnual report

    「Goodwill 353,506 277,755」

    The goodwill balance decreased from ¥353.506 million at the end of the previous consolidated fiscal year to ¥277.755 million at the end of the current interim consolidated accounting period. The disclosure does not mention any new indications of impairment.
  5. FY2024Goodwill balance declines; no indication of impairmentAnnual report

    「The Company determined that there were no indications of goodwill impairment during the current consolidated fiscal year. However, if the estimates and assumptions need to be revised due to changes in uncertain future economic conditions or other factors, an impairment loss (extraordinary loss) could arise in the consolidated financial statements for the next consolidated fiscal year.」

    The goodwill balance decreased through amortization from ¥505.009 million at the end of the previous fiscal year to ¥353.506 million, and the Company determined that there were no indications of impairment during the current fiscal year. However, the risk of impairment due to changes in future market trends, expected sales and other factors continues.
  6. FY2024-Q3Goodwill balance declines furtherAnnual report

    「Goodwill 505,009 391,382」

    The goodwill balance decreased from ¥505.009 million at the end of the previous consolidated fiscal year to ¥391.382 million at the end of the third quarter. The current disclosure does not mention any new indications of impairment.
  7. FY2024-Q2Goodwill balance decreasedAnnual report

    「Goodwill 505,009 429,258」

    The goodwill balance decreased from ¥505.009 million at the end of the previous consolidated fiscal year to ¥429.258 million. The current disclosure does not mention any new indications of impairment.
  8. FY2023Goodwill balance declines; no indication of impairmentAnnual report

    「As a result, the Company determined that there were no indications of goodwill impairment during the current consolidated fiscal year. However, if the estimates and assumptions need to be revised due to changes in uncertain future economic conditions or other factors, an impairment loss (extraordinary loss) could arise in the consolidated financial statements for the next consolidated fiscal year.」

    The goodwill balance decreased through amortization from ¥656.512 million at the end of the previous fiscal year to ¥505.009 million, and the Company determined that there were no indications of impairment during the current fiscal year. However, the risk of impairment due to future economic conditions and other factors continues to be disclosed.
  9. FY2022MitigatedAnnual report

    「As a result, the Company determined that there were no indications of goodwill impairment during the current consolidated fiscal year. However, if the estimates and assumptions need to be revised due to changes in uncertain future economic conditions or other factors, an impairment loss (extraordinary loss) could arise in the consolidated financial statements for the next consolidated fiscal year.」

    The goodwill balance decreased through amortization from ¥808.015 million to ¥656.512 million, and the Company determined that there were no indications of impairment during the current fiscal year. However, the risk of impairment due to changes in future conditions continues to be disclosed.
  10. FY2021First statedAnnual report

    「During the current consolidated fiscal year, the Company assessed whether goodwill had been impaired by reviewing the progress toward the future plans anticipated when the consolidated subsidiary was acquired. As a result, the Company determined that there were indications of goodwill impairment and assessed whether an impairment loss should be recognized.」

    The Company determined that there were indications of impairment for ¥808.015 million in goodwill arising from the acquisition of a consolidated subsidiary and assessed impairment recognition based on future cash flows and other factors. The assessment assumes that the impact of the infectious disease will largely subside during the fiscal year ending March 2022, and states that an impairment loss could arise if future conditions change.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Uex yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.